News

Pharmabiz13h
Silence Therapeutics presents additional data from phase 1 study of divesiran as potential first-in-class siRNA treatment for polycythemia vera
Silence Therapeutics presents additional data from phase 1 study of divesiran as potential first-in-class siRNA treatment for polycythemia vera: London Monday, June 16, 2025, 18:0 ...
Pharmabiz14h
EMA’s veterinary medicinal products committee recommends marketing authorization to Elanco’s Zenrelia to treat atopic dermatitis in dogs
EMA’s veterinary medicinal products committee recommends marketing authorization to Elanco’s Zenrelia to treat atopic dermatitis in dogs: Greenfield, Indiana Monday, June 16, ...
Pharmabiz15h
Alligator Bioscience receives US FDA endorsement of mitazalimab phase 3 dose for pancreatic cancer
Alligator Bioscience receives US FDA endorsement of mitazalimab phase 3 dose for pancreatic cancer: Lund, Sweden Monday, June 16, 2025, 16:30 Hrs [IST] Alligator Bioscience, a cli ...
Pharmabiz15h
Ethris collaborates with Thermo Fisher Scientific to provide access to mRNA technology platforms
Ethris collaborates with Thermo Fisher Scientific to provide access to mRNA technology platforms: Munich, Germany Monday, June 16, 2025, 16:00 Hrs [IST] Ethris GmbH, a clinical-st ...
Pharmabiz16h
Will work with partner countries to advance regulatory collaboration, says Minister Anupriya Patel
Will work with partner countries to advance regulatory collaboration, says Minister Anupriya Patel: Our Bureau, New Delhi Monday, June 16, 2025, 15:15 Hrs [IST] India continues to ...
Pharmabiz16h
Chrysalis launches with acquired cleanroom assets to deliver flexible manufacturing solutions
Chrysalis launches with acquired cleanroom assets to deliver flexible manufacturing solutions: Boston, Massachusetts Monday, June 16, 2025, 15:00 Hrs [IST] Chrysalis, a GMP-ready ...
Pharmabiz16h
Healthcare Summit 2025 hosted by IISc attracts 500 global leaders to focus on future of sector
Healthcare Summit 2025 hosted by IISc attracts 500 global leaders to focus on future of sector: Our Bureau, Bengaluru Monday, June 16, 2025, 14:45 Hrs [IST] Indian Institute of Sc ...
Pharmabiz17h
Lupin & Sino Universal Pharmaceuticals ink license and supply agreement for tiotropium DPI in China
Lupin & Sino Universal Pharmaceuticals ink license and supply agreement for tiotropium DPI in China: Our Bureau, Mumbai Monday, June 16, 2025, 14:30 Hrs [IST] Global pharma major ...
Pharmabiz17h
Ethniq positions its Skin Revive as a patented natural cure for chronic fungal infections
Ethniq positions its Skin Revive as a patented natural cure for chronic fungal infections: Our Bureau, Bengaluru Monday, June 16, 2025, 14:15 Hrs [IST] Ethniq, a new-age natural m ...
Pharmabiz17h
Johnson & Johnson’s dual-targeting CAR T-cell therapy shows encouraging first results in large B-cell lymphoma
Johnson & Johnson’s dual-targeting CAR T-cell therapy shows encouraging first results in large B-cell lymphoma: Milan Monday, June 16, 2025, 14:00 Hrs [IST] Johnson & Johnson an ...
Pharmabiz17h
Seqrite warns critical cybersecurity threats to Indian healthcare, urges immediate adoption of advanced defense measures
Seqrite warns critical cybersecurity threats to Indian healthcare, urges immediate adoption of advanced defense measures: Our Bureau, Bengaluru Monday, June 16, 2025, 13:50 Hrs [I ...
Pharmabiz18h
Orbis India sees need to handle preventive ophthalmic issues by incorporating eye screenings into primary healthcare
Orbis India sees the need to advance preventive ophthalmic issues by incorporating eye screenings into primary healthcare. This is because primary care is the first point of contact in the healthcare ...